MicroTech Medical (Hangzhou) Co., Ltd.
Research MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK) on Bullrun: market cap HKD 2.71B, P/E 30.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2235.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Devices
- CurrencyHKD
- Market capHKD 2.71B
- P/E30.0
- Financial periodFY2025
- RevenueCNY 652.02M
- Revenue growth91.6%
- Net incomeCNY 40.15M
- Free cash flow-CNY 6.31M
- Gross margin54.4%
Valuation Snapshot
latest market cap is HKD 2.71B; P/E is 30.0.
Peer valuation comparison
Latest P/E is 29.98x versus a Healthcare sector median of 21.74x (37.9% above).
Latest P/E is 29.98x versus a China median of 16.26x (84.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 652.02M | CNY 40.15M | -CNY 6.31M | 54.4% | n/a | CNY 1.51B | CNY 91.33M | CNY 2.01B |
| FY2024 | CNY 340.35M | -CNY 63.12M | -CNY 203.88M | 52.9% | -0.15 | CNY 1.70B | CNY 4.20M | CNY 1.97B |
| FY2023 | CNY 248.35M | -CNY 125.02M | -CNY 181.69M | 47.6% | -0.29 | CNY 1.89B | CNY 5.06M | CNY 2.06B |
| FY2022 | CNY 169.89M | -CNY 35.04M | -CNY 148.79M | 46.4% | -0.08 | CNY 2.05B | CNY 716.23K | CNY 2.21B |
| FY2021 | n/a | n/a | n/a | n/a | -0.13 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 2.71B | 30.0 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About MicroTech Medical (Hangzhou) Co., Ltd.
MicroTech Medical (Hangzhou) Co., Ltd. provides diabetes management, diabetes treatment, and diabetes monitoring and treatment medical devices in China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; API open platform; and diabetes digital management software.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MicroTech Medical (Hangzhou) Co., Ltd.'s market cap?
MicroTech Medical (Hangzhou) Co., Ltd.'s market capitalization is HKD 2.71B.
What is MicroTech Medical (Hangzhou) Co., Ltd.'s P/E ratio?
MicroTech Medical (Hangzhou) Co., Ltd.'s price-to-earnings (P/E) ratio is 30.0.
What does MicroTech Medical (Hangzhou) Co., Ltd. do?
MicroTech Medical (Hangzhou) Co., Ltd. provides diabetes management, diabetes treatment, and diabetes monitoring and treatment medical devices in China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; API open platform; and diabetes digital management software.